Registrer deg med din e-postadresse for å få de nyeste sakene fra SpinChip Diagnostics ASA på e-post fortløpende. Du kan melde deg av når som helst.
Representing the future of point-of-care testing, SpinChip was founded in Norway in 2012. SpinChip’s proprietary platform is focused on in-vitro diagnostics (IVD) to develop diagnostic tests for acute and chronic cardiac indications where test results are rapidly needed to provide patients with life-saving treatments. The platform is based on microfluidic technology in combination with nanotechnology-based cartridge assays, which together can relay test results as accurately as a high-sensitive laboratory diagnostic machine within minutes, with only one fraction of blood.
Visit www.spinchip.no for more information.
Representing the future of point-of-care testing, SpinChip was founded in Norway in 2012. SpinChip’s proprietary platform is focused on in-vitro diagnostics (IVD) to develop diagnostic tests for acute and chronic cardiac indications where test results are rapidly needed to provide patients with life-saving treatments. The platform is based on microfluidic technology in combination with nanotechnology-based cartridge assays, which together can relay test results as accurately as a high-sensitive laboratory diagnostic machine within minutes, with only one fraction of blood.
Visit www.spinchip.no for more information.